Bull Horn Holdings (BHSE) to Combine with Coeptis Therapeutics

Bull Horn (NASDAQ:BHSE) has entered into a definitive agreement to combine with biopharmaceutical company Coeptis (OTC:COEP). Wexford, Pennsylvania-based Coeptis is developing a pair of therapies designed to improve the efficacy of cancer treatments. The combined company is expected to trade under the symbol “COEP” once the deal is completed in the third quarter of 2022.
Read More